Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Coherus BioSciences Names Government Affairs VP | Contract Pharma
Breaking News, Promotions & Moves

Coherus BioSciences Names Government Affairs VP

Reed brings 10 years of experience specializing in global biosimilars policy

Juliana M. Reed has been appointed vice president, Government Affairs at Coherus BioSciences, Inc., a global biosimilars company. Ms. Reed has more than 10 years in government affairs, specializing in global biosimilars policy.
 
“We welcome Juliana to the Coherus team,” said Denny Lanfear, president and chief executive officer of Coherus. “Juliana is an accomplished executive who brings a wealth of experience, insight and leadership in the development of government policies that impact this new industry. The Coherus leadership team is composed of successful veterans who have helped pioneer the biologics industry. With the addition of Juliana, we now have one of the recognized leading experts on global biosimilar public policy. We look forward to working with Juliana in our efforts towards bringing affordable medications to patients and creating a vibrant marketplace for biosimilars in the US.”
 
Ms. Reed has extensive experience in governmental and public affairs in the healthcare, pharmaceutical and medical device industries, including roles with Baxter and Hospira. She led the development and execution of the Hospira global biosimilars public policy strategy for the last 10 years, prior to the recent Pfizer acquisition of Hospira. She is the current president of the Biosimilars Forum, a not for profit group representing the U.S. biosimilars industry.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters